{"id":"W4283379818","doi":"10.1097/01.hs9.0000846628.17113.b2","title":"P940: SAFETY AND CLINICAL ACTIVITY OF BELANTAMAB MAFODOTIN WITH PEMBROLIZUMAB IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM): DREAMM-4 STUDY","year":2022,"lang":"en","type":"article","venue":"HemaSphere","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; University of Calgary","funders":"","keywords":"Pembrolizumab; Medicine; Internal medicine; Adverse effect; Multiple myeloma; Oncology; Clinical endpoint; Expanded access; Clinical trial; Surgery; Gastroenterology; Immunotherapy; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004019303,0.000287479,0.0007580748,0.0001082681,0.000184302,0.00001056413,0.0001303892,0.00007838065,0.0004482442],"category_scores_gemma":[0.0001364674,0.0002068263,0.00007487523,0.0003676546,0.000169869,0.0001252373,0.0002448945,0.0007286842,0.000007353106],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002489315,"about_ca_system_score_gemma":0.0002853476,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000770542,"about_ca_topic_score_gemma":0.001647779,"domain_scores_codex":[0.9970652,0.0004254332,0.0004824653,0.0006189609,0.0009556427,0.0004523323],"domain_scores_gemma":[0.9984012,0.0003831087,0.0002322126,0.0005749241,0.0001186181,0.0002899729],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.05259193,0.01011482,0.9126233,0.00008854349,0.0004136993,0.0004795118,0.0003709138,0.00001323029,0.00002181315,0.000003763759,0.00005109618,0.02322734],"study_design_scores_gemma":[0.06026847,0.01418122,0.9236943,0.00008560438,0.0001284452,0.00003337016,0.0009114629,0.0001635777,0.00006623075,0.00000186417,0.0002771905,0.0001882427],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964956,0.0000976825,0.00001057557,0.00006443842,0.00003843636,0.002197683,0.0000996072,0.00003934608,0.0009566416],"genre_scores_gemma":[0.9987395,0.00002366999,0.0003736412,0.00002638934,0.00002417378,0.0001024318,0.00008338465,0.00005486353,0.0005719698],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0230391,"threshold_uncertainty_score":0.8434134,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01681389065278146,"score_gpt":0.2878218790884212,"score_spread":0.2710079884356397,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}